Subadditive withdrawal from cocaine/κ-opioid agonist combinations in Planaria

Brain Research

Volumn 1114, Issue 1, 2006, Pages 31-35

  Raffa, Robert B ^a   Stagliano, Gregory W ^a   Tallarida, Ronald J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

opioid; Cocaine; Planaria; U 50,488H; Withdrawal

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; COCAINE; KAPPA OPIATE RECEPTOR AGONIST;

ANIMAL BEHAVIOR; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG WITHDRAWAL; LOCOMOTION; NEUROTRANSMISSION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TURBELLARIA;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANESTHETICS, LOCAL; ANIMALS; BEHAVIOR, ADDICTIVE; BEHAVIOR, ANIMAL; COCAINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; PLANARIANS; RECEPTORS, OPIOID, KAPPA; SUBSTANCE WITHDRAWAL SYNDROME;

PLANARIA;

EID: 33748765810     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.07.037     Document Type: Article

References (30)

1. Ahmed S.H., and Koob G.F. Transition from moderate to excessive drug intake: change in hedonic set point. Science 282 (1998) 298-300
2. Algeri S., Carolei A., Ferretti P., Gallone C., Palladini G., and Venturini G. Effects of dopaminergic agents on monoamine levels and motor behaviour in Planaria. Comp. Biochem. Physiol. 74C (1983) 27-29
3. Bliss C.I. The toxicity of poisons applied jointly. Ann. Appl. Biol. 26 (1939) 585-615
4. Carolei A., Margotta V., and Palladini G. Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations. Neuropsychobiology 1 (1975) 355-364
5. Collins S.L., D'Addario C., and Izenwasser S. Effects of kappa-opioid receptor agonists on long-term cocaine use and dopamine neurotransmission. Eur. J. Pharmacol. 426 (2001) 25-34
6. Filip M., Nowak E., Papla I., and Przegaliski E. Role of 5-hydroxytryptamine1B receptors and 5-hydroxytryptamine uptake inhibition in the cocaine-evoked discriminative stimulus effects in rats. J. Physiol. Pharmacol. 52 (2001) 249-263
7. Finney D.J. The analysis of toxicity tests on mixtures of poisons. Ann. Appl. Biol. 29 (1942) 82-94
8. Koob G.F., and Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 278 (1997) 52-58
9. Palladini G., Ruggieri S., Stocchi F., De Pandis M.F., Venturini G., and Margotta V. A pharmacological study of cocaine activity in planaria. Comp. Biochem. Physiol., C 115 (1996) 41-45
10. Passarelli F., Merante A., Pontieri F.E., Margotta V., Venturini G., and Palladini G. Opioid-dopamine interaction in planaria: a behavioral study. Comp. Biochem. Physiol., C 124 (1999) 51-55
11. Raffa R.B., and Desai P. Description and quantification of cocaine withdrawal signs in Planaria. Brain Res. 1032 (2005) 200-202
12. Raffa R.B., and Valdez J.M. Cocaine withdrawal in Planaria. Eur. J. Pharmacol. 430 (2001) 143-145
13. Raffa R.B., Holland L.J., and Schulingkamp R.J. Quantitative assessment of dopamine D2 antagonist activity using invertebrate (Planaria) locomotion as a functional endpoint. J. Pharmacol. Toxicol. Methods 45 (2001) 223-226
14. Raffa R.B., Stagliano G.W., and Umeda S. κ-Opioid withdrawal in Planaria. Neurosci. Lett. 349 (2003) 139-142
15. Sasaki-Adams D.M., and Kelley A.E. Serotonin-dopamine interactions in the control of conditioned reinforcement and motor behavior. Neuropsychopharmacology 25 (2001) 440-452
16. Self D.W., and Nestler E.J. Relapse to drug-seeking: neural and molecular mechanisms. Drug Alcohol Depend. 51 (1998) 49-60
17. Sharpe L.G., Pilotte N.S., Shippenberg T.S., Goodman C.B., and London E.D. Autoradiographic evidence that prolonged withdrawal from intermittent cocaine reduces mu-opioid receptor expression in limbic regions of the rat brain. Synapse 37 (2000) 292-297
18. Tallarida R.J. Statistical analysis of drug combinations for synergism. Pain 49 (1992) 93-97
19. Tallarida R.J. Drug Synergism and Dose-Effect Data (2000), Chapman and Hall/CRC Press, Boca Raton, FL
20. Tallarida R.J., Stone Jr. D.J., and Raffa R.B. Efficient designs for studying synergistic drug combinations. Life Sci. 61 (1997) PL417-PL425
21. Tallarida R.J., Kimmel H.L., and Holtzman S.G. Theory and statistics of detecting synergism between two active drugs: cocaine and buprenorphine. Psychopharmacology 133 (1997) 378-382
22. Tallarida R.J., Stone Jr. D.J., McCary J.D., and Raffa R.B. A response surface analysis of synergism between morphine and clonidine. J. Pharmacol. Exp. Ther. 289 (1999) 8-13
23. Turchan J., Przewlocka B., Lason W., and Przewlocki R. Effects of repeated psychostimulant administration on the prodynorphin system activity and kappa opioid receptor density in the rat brain. Neuroscience 85 (1998) 1051-1059
24. Umeda S., Stagliano G.W., and Raffa R.B. Cocaine and κ-opioid withdrawal in Planaria blocked by d-, but not l-glucose. Brain Res. 1018 (2004) 181-185
25. Venturini G., Carolei A., Palladini G., Margotta V., and Lauro M.G. Radioimmunological and immunocytochemical demonstration of Met-enkephalin in planaria. Comp. Biochem. Physiol. 74 (1983) 23-25
26. Venturini G., Stocchi F., Margotta V., Ruggieri S., Bravi D., Bellantuono P., and Palladini G. A pharmacological study of dopaminergic receptor in Planaria. Neuropharmacology 28 (1989) 1377-1382
27. Wang N.S., Brown V.L., Grabowski J., and Meisch R.A. Reinforcement by orally delivered methadone, cocaine, and methadone-cocaine combinations in rhesus monkeys: are the combinations better reinforcers?. Psychopharmacology 156 (2001) 63-72
28. Welsh J.H., and Williams L.D. Monoamine containing neurons in Planaria. J. Comp. Neurol. 138 (1970) 103-116
29. Woolfolk D.R., and Holtzman S.G. The effects of opioid receptor antagonism on the discriminative stimulus effects of cocaine and d-amphetamine in the rat. Behav. Pharmacol. 7 (1996) 779-787
30. Yuferov V., Zhou Y., LaForge K.S., Spangler R., Ho A., and Kreek M.J. Elevation of guinea pig brain preprodynorphin mRNA expression and hypothalamic-pituitary-adrenal axis activity by "binge" pattern cocaine administration. Brain Res. Bull. 55 (2001) 65-70